Dr. Gopal Chalavarya, MD
What this data tells you about Dr. Chalavarya
Dr. Gopal Chalavarya is a cardiovascular disease in Hudson, FL, with 20 years in practice. Based on federal Medicare data, Dr. Chalavarya performed 7,098 Medicare services across 2,225 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chalavarya received a total of $28,615 from 28 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chalavarya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 3,500 | $0 | $1 |
| Office visit, established patient (20-29 min) | 1,040 | $63 | $138 |
| Hospital follow-up visit, moderate complexity | 386 | $62 | $100 |
| Injection, dipyridamole, per 10 mg | 337 | $3 | $10 |
| EKG interpretation and report | 251 | $6 | $18 |
| Electrocardiogram (EKG), 12-lead | 247 | $10 | $75 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 174 | $351 | $900 |
| Infusion, normal saline solution, 250 cc | 130 | $1 | $5 |
| Echocardiogram, transthoracic | 128 | $140 | $397 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 127 | $46 | $150 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $329 | $600 |
| Regadenoson injection (Lexiscan) for heart stress test | 108 | $38 | $75 |
| Initial hospital admission, high complexity | 103 | $131 | $300 |
| Injection, aminophyllin, up to 250 mg | 78 | $7 | $20 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 76 | $88 | $260 |
| New patient office visit (30-44 min) | 68 | $78 | $210 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 45 | $9 | $25 |
| Programming of dual lead pacemaker system | 33 | $61 | $98 |
| Remote pacemaker/defibrillator monitoring, 90 days | 33 | $16 | $55 |
| Remote pacemaker monitoring, 90 days | 24 | $23 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $38 | $110 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $49 | $150 |
| Evaluation of implantable heart and blood vessel monitoring system | 16 | $33 | $55 |
| Office visit, established patient (30-39 min) | 13 | $100 | $195 |
| Cardiac catheterization | 11 | $204 | $650 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chalavarya is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), and high industry engagement (mixed engagement, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chalavarya experienced with contrast dye for imaging (iodine-based)?
Does Dr. Chalavarya receive payments from pharmaceutical companies?
How do Dr. Chalavarya's costs compare to other cardiovascular diseases in Hudson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology